Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

Drugs

Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits

February 4, 2025

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary

Ipca Laboratories Ltd Q2FY25; 81% rise in Profits

January 3, 2025

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q2FY25 of ₹2,355.00

Neuland Laboratories Ltd Q3FY24; 161% rise in Profits

February 8, 2024February 8, 2024

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top